Improving glycemic and cholesterol control through an integrated approach incorporating colesevelam – a clinical perspective

References

• GaedePLund-AndersenHParvingHHPedersenOEffect of a multifactorial intervention on mortality in type 2 diabetesN Engl J Med2008358658059118256393
   PubMed Web of Science ®Google Scholar
• ColhounHMBetteridgeDJDurringtonPNCARDS investigatorsPrimary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trialLancet2004364943568569615325833
   PubMed Web of Science ®Google Scholar
• NathanDMClearyPABacklundJYDiabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research GroupIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetesN Engl J Med2005353252643265316371630
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationStandards of medical care in diabetes-2008Diabetes Care200831Suppl 1S12S5418165335
   PubMed Web of Science ®Google Scholar
• AACE medical guidelinesEndocr Pract200712Suppl 1468
   Google Scholar
• National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA20012852486249711368702
   PubMed Web of Science ®Google Scholar
• HoergerTJSegelJEGreggEWSaaddineJBIs glycemic control improving in US. adults?Diabetes Care2008311818617934153
   PubMed Web of Science ®Google Scholar
• JacobsMJKleisliTPioJRPrevalence and control of dyslipidemia among persons with diabetes in the United StatesDiabetes Res Clin Pract200570326326915890427
   PubMed Web of Science ®Google Scholar
• BloomgardenZTDodisRViscoliCMHolmboeESInzucchiSELower baseline glycemia reduces apparent oral agent glucose-lowering efficacy: a meta-regression analysisDiabetes Care20062992137213916936168
   PubMed Web of Science ®Google Scholar
• NathanDMBuseJBDavidsonMBMedical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of DiabetesDiabetologia2009521173018941734
   PubMed Web of Science ®Google Scholar
• JellingerPSDavidsonJARoad maps to achieve glycemic control in type 2 diabetes mellitus: ACE/AACE Diabetes Road Map Task ForceEndocr Pract200713326026817599857
   PubMedGoogle Scholar
• Van ItallieTBHashimSACramptonRSTennentDMThe treatment of pruritus and hypercholesteremia of primary biliary cirrhosis with cholestyramineN Engl J Med196126546947413779996
   PubMed Web of Science ®Google Scholar
• The Lipid Research Clinics Coronary Primary Prevention Trial results. 1. Reduction in incidence of coronary heart diseaseJAMA19842513513646361299
   PubMed Web of Science ®Google Scholar
• HunninghakeDBSteinEABremnerWFDose response study of colestipol tablets in patients with moderate hypercholesterolemiaAm J Ther1995218018911847550
   PubMedGoogle Scholar
• PanHYDeVauttARSwilesBJPharmacokinetics and pharmacodynamics of pravastatin alone and with cholestyramine in hypercholesterolemiaClin Pharmacol Ther1990482012072116260
   PubMed Web of Science ®Google Scholar
• SprecherDLAbramsJAllenJWLow-dose combined therapy with fluvastatin and cholestyramine in hyperlipidemic patientsAnn Intern Med19941205375438093139
   PubMed Web of Science ®Google Scholar
• DenkeMAGrundySMEfficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemiaArch Intern Med19951553933997848022
   PubMedGoogle Scholar
• SchrottHGSteinEADujovneCAEnhanced low-density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapyAm J Cardiol19957534397801861
   PubMed Web of Science ®Google Scholar
• BlankenhornDHNessimSAJohnsonRLBeneficial effects of combined colestipolniaein therapy on coronary atherosclerosis and coronary venous bypass graftsJAMA1987257323332403295315
   PubMed Web of Science ®Google Scholar
• HoulstonRQuineyJWattsGFGemfibrozil in the treatment of resistant familial hypercholesterolaemia and type 111 hyperlipoproteinaemiaJ R Soc Med1988812742763164409
   PubMed Web of Science ®Google Scholar
• InsullW JrClinical utility of bile acid sequestrants in the treatment of dyslipidemia: a scientific reviewSouth Med J200699325727316553100
   PubMed Web of Science ®Google Scholar
• ProutTEA prospective view of the treatment of adult-onset diabetes with special reference to the University Group Diabetes Program and oral hypoglycemic agentsMed Clin North Am1971554106510754946757
   PubMed Web of Science ®Google Scholar
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) UK Prospective Diabetes Study (UKPDS) GroupLancet199835291318548659742977
   PubMed Web of Science ®Google Scholar
• NissenSEWolskiKEffect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causesN Engl J Med2007356242457247117517853
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration Available at: http://www.fda.gov/bbs/topics/NEWS/2008/NEW01928.html
   Google Scholar
• KeechASimesRJBarterPEffects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trialLancet200536695001849186116310551
   PubMed Web of Science ®Google Scholar
• BuchwaldHVarcoRLMattsJPEffect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)N Engl J Med1990323149469552205799
   PubMed Web of Science ®Google Scholar
• BrensikeJFLevyRIKelseySFEffects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention StudyCirculation1984693133246360414
   PubMed Web of Science ®Google Scholar
• KaneJPMalloyMJPortsTARegression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimensJAMA1990264300730122243428
   PubMed Web of Science ®Google Scholar
• WhitneyEJKrasuskiRAPersoniusBEA randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical eventsAnn Intern Med200514295l0415657157
   PubMed Web of Science ®Google Scholar
• StuderMBrielMLeimenstollBEffect of different antilipidemic agents and diets on mortality: a systematic reviewArch Intern Med200516572573015824290
   PubMed Web of Science ®Google Scholar
• DavidsonMHDillonMAGordonBColesevelam hydrochloride (Cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effectsArch Intern Med19991591893190010493319
   PubMed Web of Science ®Google Scholar
• InsullW JrTothPMullicanWEffectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trialMayo Clin Proc20017697198211605698
   PubMed Web of Science ®Google Scholar
• DavidsonMHTothPWeissSLow-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemiaClin Cardiol20012446747411403509
   PubMed Web of Science ®Google Scholar
• KnappHHSchrottHMaPEfficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemiaAm J Med200111035236011286949
   PubMed Web of Science ®Google Scholar
• HunninghakeDInsullW JrTothPCoadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additivelyAtherosclerosis200115840741611583720
   PubMed Web of Science ®Google Scholar
• ClaudelTSturmEDuezHBile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response elementJ Clin Invest2002109796197111927623
   PubMed Web of Science ®Google Scholar
• CrouseJR 3rdHypertriglyceridemia: a contraindication to the use of bile acid binding resinsAm J Med19878322432483618626
   PubMed Web of Science ®Google Scholar
• BeilUCrouseJREinarssonKGrundySMEffects of interruption of the enterohepatic circulation of bile acids on the transport of very low density lipoprotein triglyceridesMetabolism1982314384447078426
   PubMed Web of Science ®Google Scholar
• HirokaneHNakaharaMTachibanaSShimizuMSatoRBile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4J Biol Chem200427944456854569215337761
   PubMed Web of Science ®Google Scholar
• GoldbergRBFonsecaVATruittKEJonesMREfficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapyArch Intern Med2008168141531154018663165
   PubMedGoogle Scholar
• RosensonRSColesevelam HCl reduces LDL particle number and increases LDL size in hypercholesterolemiaAtherosclerosis2006185232733016009365
   PubMed Web of Science ®Google Scholar
• RosensonRSAbbySLJonesMRColesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetesAtherosclerosis2008 [Epub ahead of print] PMID: 18996525
   Web of Science ®Google Scholar
• SirventAVerhoevenAJJansenHFarnesoid X receptor represses hepatic lipase gene expressionJ Lipid Res200445112110211515342685
   PubMed Web of Science ®Google Scholar
• XydakisAMGuytonJRChiouPEffectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemiaAm J Cardiol20049479579715374793
   PubMed Web of Science ®Google Scholar
• ZemaMJColesevelam HCl and ezetimibe combination therapy provides effective lipid-lowering in difficult-to-treat patients with hypercholesterolemiaAm J Ther200512430631016041193
   PubMedGoogle Scholar
• McKenneyJJonesMAbbySSafety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment ofmixed hyperlipidemiaCurr Med Res Opin2005211403141216197659
   PubMed Web of Science ®Google Scholar
• GargAGrundySMCholestyramine therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. A short-term, double-blind, crossover trialAnn Intern Med19941214164228053615
   PubMed Web of Science ®Google Scholar
• ZieveFJKalinMFSchwartzSLResults of the glucose-lowering effect of WelChol study GLOWS: a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetesClin Ther200729748317379048
   PubMed Web of Science ®Google Scholar
• FonsecaVARosenstockJWangACTruittKEJonesMRColesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapyDiabetes Care20083181479148418458145
   PubMed Web of Science ®Google Scholar
• BaysHEGoldbergRBTruittKEJonesMRColesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effectsArch Intern Med2008168181975198318852398
   PubMedGoogle Scholar
• DevarajSAutretBJialalIEffects of colesevelam hydrochloride (WelChol) on biomarkers of inflammation in patients with mild hypercholesterolemiaAm J Cardiol200698564164316923452
   PubMed Web of Science ®Google Scholar
• DonovanJMStypinskiDStilesMROlsonTABurkeSKDrug interactions with colesevelam hydrochloride, a novel, potent lipid-lowering agentCardiovasc Drugs Ther200014668169011300370
   PubMed Web of Science ®Google Scholar
• Welchol prescribing information Available at http://www.welchol.com/pdf/Welchol_PI.pdf
   Google Scholar
• ThomsonABKeelanMFeeding rats diets containing cheno1365–71 or ursodeoxycholic acid or cholestyramine modifies intestinal uptake of glucose and lipidsDigestion19873831601703443226
   PubMed Web of Science ®Google Scholar
• BrandSJMorganRGStimulation of pancreatic secretion and growth in the rat after feeding cholestyramineGastroenterology1982838518597106515
   PubMed Web of Science ®Google Scholar
• StaelsBKuipersFBile acid sequestrants and the treatment of type 2 diabetes mellitusDrugs200767101383139217600387
   PubMed Web of Science ®Google Scholar
• NathanDMDavidsonMBDeFronzoRAAmerican Diabetes AssociationImpaired fasting glucose and impaired glucose tolerance: implications for careDiabetes Care200730375375917327355
   PubMed Web of Science ®Google Scholar